Aspen Valley Hospital Center For Medical Care | |
401 Castle Creek Rd Aspen CO 81611 | |
(970) 544-1261 | |
(970) 544-1585 |
Full Name | Aspen Valley Hospital Center For Medical Care |
---|---|
Speciality | Clinic/Center |
Location | 401 Castle Creek Rd, Aspen, Colorado |
Authorized Official Name and Position | Steven Knowles (COMPLIANCE OFFICER) |
Authorized Official Contact | 9705441551 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Aspen Valley Hospital Center For Medical Care 401 Castle Creek Rd Aspen CO 81611-1159 Ph: (970) 544-1261 | Aspen Valley Hospital Center For Medical Care 401 Castle Creek Rd Aspen CO 81611 Ph: (970) 544-1261 |
NPI Number | 1003306168 |
---|---|
Provider Enumeration Date | 05/15/2018 |
Last Update Date | 03/27/2024 |
Medicare PECOS PAC ID | 3375891013 |
---|---|
Medicare Enrollment ID | O20180813000798 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1003306168 | NPI | - | NPPES |
Provider Name | Kelly T Locke |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1376546002 PECOS PAC ID: 5991778854 Enrollment ID: I20040818000560 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Karen C Locke |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1992708622 PECOS PAC ID: 4789657644 Enrollment ID: I20040818000577 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Lesley A Fraser |
---|---|
Provider Type | Practitioner - General Surgery |
Provider Identifiers | NPI Number: 1154309011 PECOS PAC ID: 2769405158 Enrollment ID: I20060111001161 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Joseph L Schuller |
---|---|
Provider Type | Practitioner - Cardiac Electrophysiology |
Provider Identifiers | NPI Number: 1144367434 PECOS PAC ID: 5991866931 Enrollment ID: I20081209000243 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Rebecca E Laird |
---|---|
Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
Provider Identifiers | NPI Number: 1063568749 PECOS PAC ID: 5092870477 Enrollment ID: I20090218000593 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Gordon M Gerson |
---|---|
Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
Provider Identifiers | NPI Number: 1750384699 PECOS PAC ID: 1951468347 Enrollment ID: I20090330000732 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Laureen P Osier |
---|---|
Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
Provider Identifiers | NPI Number: 1538301312 PECOS PAC ID: 7719037225 Enrollment ID: I20090603000650 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Elizabeth C Brew |
---|---|
Provider Type | Practitioner - General Surgery |
Provider Identifiers | NPI Number: 1962519363 PECOS PAC ID: 7911944913 Enrollment ID: I20100204000840 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Peter M Zonakis |
---|---|
Provider Type | Practitioner - Otolaryngology |
Provider Identifiers | NPI Number: 1083606834 PECOS PAC ID: 0042291924 Enrollment ID: I20130621000045 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Thomas Maxwell Fissenden |
---|---|
Provider Type | Practitioner - Otolaryngology |
Provider Identifiers | NPI Number: 1851682090 PECOS PAC ID: 6406147289 Enrollment ID: I20160627000214 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Michael L Murphy |
---|---|
Provider Type | Practitioner - Ophthalmology |
Provider Identifiers | NPI Number: 1205893880 PECOS PAC ID: 1153216270 Enrollment ID: I20170104000561 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Heather C Murphy |
---|---|
Provider Type | Practitioner - Otolaryngology |
Provider Identifiers | NPI Number: 1013024439 PECOS PAC ID: 7315969649 Enrollment ID: I20170104000781 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Christopher A. Roseberry |
---|---|
Provider Type | Practitioner - General Surgery |
Provider Identifiers | NPI Number: 1326099847 PECOS PAC ID: 7517978711 Enrollment ID: I20180919000769 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Ali Mashfaque Mohammed Samee |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1871909333 PECOS PAC ID: 6800136169 Enrollment ID: I20190328000616 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Zach D Hartman |
---|---|
Provider Type | Practitioner - General Surgery |
Provider Identifiers | NPI Number: 1528358173 PECOS PAC ID: 3678714714 Enrollment ID: I20190819001132 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Dustin Jm Anderson |
---|---|
Provider Type | Practitioner - Physical Medicine And Rehabilitation |
Provider Identifiers | NPI Number: 1265827737 PECOS PAC ID: 2668765074 Enrollment ID: I20191011000832 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Edward A Wiese |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1235196866 PECOS PAC ID: 0941345219 Enrollment ID: I20191024001650 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Michelle Miscione |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1225689342 PECOS PAC ID: 4284068735 Enrollment ID: I20191217000509 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Patrick T Lally |
---|---|
Provider Type | Practitioner - Ophthalmology |
Provider Identifiers | NPI Number: 1447253331 PECOS PAC ID: 6103906128 Enrollment ID: I20200507001551 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Ellen Chance Sanders |
---|---|
Provider Type | Practitioner - Ophthalmology |
Provider Identifiers | NPI Number: 1952586620 PECOS PAC ID: 7810057965 Enrollment ID: I20200827002220 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Lauren Victoria Mitchell |
---|---|
Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
Provider Identifiers | NPI Number: 1881210110 PECOS PAC ID: 4183035231 Enrollment ID: I20201123001019 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Tiffany M Poss |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1295338853 PECOS PAC ID: 3274944715 Enrollment ID: I20201204000966 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Rahul Shah |
---|---|
Provider Type | Practitioner - Pediatric Medicine |
Provider Identifiers | NPI Number: 1558748848 PECOS PAC ID: 0143579722 Enrollment ID: I20210524000594 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Jeffrey S Krivit |
---|---|
Provider Type | Practitioner - Otolaryngology |
Provider Identifiers | NPI Number: 1225087281 PECOS PAC ID: 3870496953 Enrollment ID: I20220405000034 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Caroline Taylor Mears |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1164981270 PECOS PAC ID: 0345624086 Enrollment ID: I20220830003472 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Catherine Chamberlin |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1457648420 PECOS PAC ID: 2466612981 Enrollment ID: I20230302002288 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Lauren Prest |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1881012235 PECOS PAC ID: 3971804147 Enrollment ID: I20230417000913 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Mark D Alter |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1730263617 PECOS PAC ID: 5991855330 Enrollment ID: I20230421002680 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Rhonda R Lampen |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1760412621 PECOS PAC ID: 2163477308 Enrollment ID: I20230425001255 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Tushar Murli Advani |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1881918415 PECOS PAC ID: 9739461484 Enrollment ID: I20230505000010 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Taha Ansari |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1538512629 PECOS PAC ID: 0749515948 Enrollment ID: I20230505002564 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Nora Ekeanya |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1154749844 PECOS PAC ID: 8628370467 Enrollment ID: I20230506000033 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Jamie L Evans |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1962664789 PECOS PAC ID: 6901044379 Enrollment ID: I20230508002912 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Melissa Somers |
---|---|
Provider Type | Practitioner - Otolaryngology |
Provider Identifiers | NPI Number: 1083815559 PECOS PAC ID: 8123296589 Enrollment ID: I20230628002820 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Vadankumar Patel |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1538100730 PECOS PAC ID: 4082519129 Enrollment ID: I20230724004127 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Mary Fahrmeier |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1245252303 PECOS PAC ID: 4880657527 Enrollment ID: I20230822004312 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Jeremiah Brewer |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1679968697 PECOS PAC ID: 8426366378 Enrollment ID: I20230823004556 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Patric Knecht |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1376078717 PECOS PAC ID: 4284908633 Enrollment ID: I20230825000653 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Provider Name | Kate Moyer |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1497530984 PECOS PAC ID: 9739533233 Enrollment ID: I20231003001557 |
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
News Archive
Body mass index (BMI) or a change in BMI is often the sole measure used to evaluate whether an intervention intended to combat childhood obesity is effective. But a new study clearly shows that an intervention can have beneficial effects on other health outcomes, such as cardiovascular fitness, regardless of its effect on BMI.
Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.
Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).
› Verified 8 days ago
Scl Health Medical Group - Grand Junction, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 401 Castle Creek Rd, Aspen, CO 81611 Phone: 970-298-5864 Fax: 970-298-5889 | |
Aspen Medical Care, Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 101 Founders Pl, Suite 109, Aspen, CO 81611 Phone: 970-920-0104 Fax: 970-920-0124 | |
Valley View Hospital Association Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 132 W Main St Ste A, Aspen, CO 81611 Phone: 970-384-7510 Fax: 970-384-7511 | |
Paula Kadison, Md Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 100 E Main St Ste 2, Aspen, CO 81611 Phone: 970-379-1240 Fax: 970-925-2597 | |
Valley View Hospital Association Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 132 W Main St Ste A, Aspen, CO 81611 Phone: 970-384-7510 Fax: 970-384-7511 | |
The Porter Medical Group P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 11 Salvation Circle, Aspen, CO 81611 Phone: 833-249-8777 |